Lycopene: A Review of Its Potential as an Anticancer Agent
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
627-635
Author(s):
V. Bhuvaneswari and S. Nagini
Novel Drugs for Neuroblastoma
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
2
Page:
527-535
Author(s):
Elzbieta Izbicka and Tadeusz Izbicki
Emerging Insights in the Role of Tissue Factor in Cancer
Journal:
Current Genomics
Volume:
6
Page:
375-382
Author(s):
H. H. Versteeg
Coagulation and Cancer Therapy: The Potential of Natural Compounds
Journal:
Current Genomics
Volume:
6
Page:
461-469
Author(s):
G. Z. Justo and C. V. Ferreira
γ-Secretase as a Therapeutic Target for the Treatment of Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3363-3382
Author(s):
I. Churcher and D. Beher
RNA Interference-Based Gene Silencing in Mice: The Development of a Novel Therapeutical Strategy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3405-3419
Author(s):
B. Spankuch and K. Strebhardt
HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy
Journal:
Current Gene Therapy
Volume:
5
Page:
445-457
Author(s):
Alberto L. Epstein, Peggy Marconi, Rafaela Argnani and Roberto Manservigi
Animal Models for Growth Hormone Gene Therapy
Journal:
Current Gene Therapy
Volume:
5
Page:
493-509
Author(s):
Cibele N. Peroni, Peter W. Gout and Paolo Bartolini
Melanoma Immunotherapy: Past, Present, and Future
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3461-3473
Author(s):
F. Saleh, W. Renno, I. Klepacek, G. Ibrahim, S. Asfar, H. Dashti, P. Romero, A. Dashti and A. Behbehani
Direct Evidence on the Immune-Mediated Spontaneous Regression of Human Cancer: An Incentive for Pharmaceutical Companies to Develop a Novel Anti-Cancer Vaccine
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3531-3543
Author(s):
F. Saleh, I. Klepacek, G. Ibrahim, H. Dashti, S. Asfar, A. Behbehani, H. Al-Sayer and A. Dashti